Chronic Cerebral Ischemia: From Pathogenesis to Therapy
Keywords:
cerebrovascular disease, cerebral microangiopathy, arterial hypertension, endothelial dysfunction, DivasaAbstract
Currently, there is an increase in the prevalence of cerebrovascular diseases, which significantly reduce the quality of life and often lead to disability of patients. Diseases of small-caliber cerebral vessels account for about 40% of dementias in the world and a fifth of strokes that occur throughout the year worldwide. Structural damage to the brain associated with cerebral microangiopathy (diffuse white matter lesions, multiple lacunar infarctions, microbleeds, secondary cerebral atrophy) can remain clinically unnoticeable for a long time, but significantly increase the risk of dementia and disabling strokes. The main etiopathogenetic factor of cerebral microangiopathy is arterial hypertension, causing arteriosclerosis of small penetrating arteries and arterioles. The most important initiating link in this process is endothelial dysfunction. Available data indicate an increase in circulating markers of endothelial damage in patients with cerebral microangiopathy. Timely complex therapy is a decisive factor in the reverse development of endothelial dysfunction and reliable prevention of cerebrovascular disease. The drug Divaza, which has pleiotropic effects, is a pathogenetically substantiated adjuvant drug for the treatment of anxiety-depressive symptoms associated with cerebral microangiopathy.
References
S. Alisherovna и др., «A Modern Approach to Risk Stratification in Patients with Heart Failure with Preserved and Reduced Ejection Fraction», Web Sci. Int. Sci. Res. J., т. 3, вып. 5, сс. 73–81, 2022.
G. Madjidova, G. Sunnatova, и S. Usarov, «About the System of Treatment of Patients with Acute Coronary Syndrome», Eurasian J. Med. Nat. Sci., т. 2, вып. 5, сс. 197–204, 2022.
J. Smith и T. Brown, «Advances in Myocardial Infarction Treatment: A Review of Current Strategies and Future Directions», J. Cardiol. Res., т. 45, вып. 2, сс. 89–102, 2023.
S. Alisherovna и др., «Clinical and Diagnostic Features of Myocardial Infarction in Young Patients in Emergency Medicine», Web Sci. Int. Sci. Res. J., т. 2, вып. 04, сс. 414–418, 2021.
N. Samadova и др., «Clinical and Diagnostic Features of Myocardial Infarction in Young Patients in Emergency Medicine», E-Conf. Globe, сс. 16–19, 2021.
G. Madjidova, G. Sunnatova, и N. Hamidov, «Clinical and Hemodynamic Conditions and Heart Natriuretic Peptides in the Blood Plasma of Patients with Hypertrophic Cardiomyopathy», Eurasian J. Med. Nat. Sci., т. 2, вып. 5, сс. 211–219, 2022.
S. Alisherovna и др., «Course of Myocardial Infarction in Young Women», Eurasian Med. Res. Period., т. 7, сс. 106–111, 2022.
G. Madjidova и др., «Nutritional Support for Patients with Coronavirus Infection», Tex. J. Med. Sci., т. 13, сс. 22–30, 2022.
N. Samadova и др., «Shoshilinch Tibbiy Yordamda Yosh Bemorlarda Miokard Infarktining Klinik va Diagnostik Xususiyatlari», Mag. Cardiorespir. Res., т. 2, вып. 1, сс. 78–81, 2021.
K. Muinova и др., «The role of risk factors in the development of myocardial infarction in young men depending on family history», Achiev. Sci. Educ., вып. 11 (52), сс. 70–74, 2019.
